Aogi K - Search Results

1

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.

Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I; DESTINY-Breast01 Investigators. Modi S, et al. Among authors: aogi k. N Engl J Med. 2020 Feb 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11. N Engl J Med. 2020. PMID: 31825192 Free PMC article. Clinical Trial.

2

Progressive central nervous system metastases in responder patients for outside central nervous system metastases on trastuzumab-based therapy--report of two cases of refractory breast cancer.

Okita R, Saeki T, Takashima S, Aogi K, Ohsumi S. Okita R, et al. Among authors: aogi k. Hiroshima J Med Sci. 2005 Mar;54(1):35-8. Hiroshima J Med Sci. 2005. PMID: 15847063

3

[Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer].

Tsutani Y, Saeki T, Aogi K, Ohsumi S, Takashima S. Tsutani Y, et al. Among authors: aogi k. Gan To Kagaku Ryoho. 2005 Jun;32(6):809-13. Gan To Kagaku Ryoho. 2005. PMID: 15984521 Clinical Trial. Japanese.

4

A case of metastatic breast cancer with HER2 gene amplification that responded completely to single agent trastuzumab.

Tsutani Y, Ohsumi S, Aogi K, Taira N, Kataoka M, Hamamoto Y, Nishimura R, Takashima S. Tsutani Y, et al. Among authors: aogi k. Breast Cancer. 2006;13(4):374-7. doi: 10.2325/jbcs.13.374. Breast Cancer. 2006. PMID: 17146166 Free article.

5

Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.

Saeki T, Nomizu T, Toi M, Ito Y, Noguchi S, Kobayashi T, Asaga T, Minami H, Yamamoto N, Aogi K, Ikeda T, Ohashi Y, Sato W, Tsuruo T. Saeki T, et al. Among authors: aogi k. J Clin Oncol. 2007 Feb 1;25(4):411-7. doi: 10.1200/JCO.2006.08.1646. Epub 2006 Dec 18. J Clin Oncol. 2007. PMID: 17179098 Clinical Trial.

6

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, Takashima S. Tokudome N, et al. Among authors: aogi k. Anticancer Drugs. 2008 Aug;19(7):753-9. doi: 10.1097/CAD.0b013e328302eb15. Anticancer Drugs. 2008. PMID: 18594220 Clinical Trial.

7

[Efficacy of vinorelbine monotherapy in advanced and metastatic breast cancer].

Suehisa H, Aogi K, Hara F, Takabatake D, Takashima S, Ohsumi S, Takashima S, Komatsubara K. Suehisa H, et al. Among authors: aogi k. Gan To Kagaku Ryoho. 2008 Oct;35(10):1709-12. Gan To Kagaku Ryoho. 2008. PMID: 18931573 Japanese.

8

Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.

Matsumoto K, Shimizu C, Arao T, Andoh M, Katsumata N, Kohno T, Yonemori K, Koizumi F, Yokote H, Aogi K, Tamura K, Nishio K, Fujiwara Y. Matsumoto K, et al. Among authors: aogi k. J Proteome Res. 2009 Feb;8(2):457-62. doi: 10.1021/pr800655p. J Proteome Res. 2009. PMID: 19140672

9

Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment.

Suzuki Y, Tokuda Y, Fujiwara Y, Iwata H, Sasaki Y, Saji S, Aogi K, Nambu Y, Suri A, Saeki T, Takashima S. Suzuki Y, et al. Among authors: aogi k. Jpn J Clin Oncol. 2009 Nov;39(11):699-706. doi: 10.1093/jjco/hyp103. Epub 2009 Sep 22. Jpn J Clin Oncol. 2009. PMID: 19776022 Clinical Trial.

10

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer.

Toi M, Sperinde J, Huang W, Saji S, Winslow J, Jin X, Tan Y, Ohno S, Nakamura S, Iwata H, Masuda N, Aogi K, Morita S, Petropoulos C, Bates M. Toi M, et al. Among authors: aogi k. BMC Cancer. 2010 Feb 23;10:56. doi: 10.1186/1471-2407-10-56. BMC Cancer. 2010. PMID: 20178580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page